• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

SLC2A3 Gene Record

  • Summary
  • Interactions
  • Claims
  • SLC2A3 6515 Druggable Genome

    Alternate Names:

    6515
    SOLUTE CARRIER FAMILY 2 MEMBER 3
    SLC2A3
    GLUT3
    138170
    11007
    ENSG00000059804
    OTTHUMG00000133685
    P11169
    SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER, MEMBER 3 (GLUCOSE TRANSPORTER TYPE 3, BRAIN). [SOURCE:UNIPROT/SWISSPROT;ACC:P11169]
    Solute carrier family 2, facilitated glucose transporter member 3

    Gene Info:

    Target Class Transporters
    Target Subclass TC:2.A.1.1.91
    Human Readable Name DRUGGABLE GENOME
    Gene Biotype PROTEIN_CODING
    (2 More Sources)

    Gene Categories: Category Details

    TRANSPORTER
    DRUGGABLE GENOME

    Publications:

    Park JB, 2001, Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells., J Nat Prod
    Augustin et al., 2003, Mitogenic and anti-apoptotic activity of insulin on bovine embryos produced in vitro., Reproduction
  • GLUFOSFAMIDE   SLC2A3

    Interaction Score: 2.58

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Glufosfamide
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • RESVERATROL   SLC2A3

    Interaction Score: 0.9

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11277764


    Sources:
    DTC

  • INSULIN   SLC2A3

    Interaction Score: 0.81

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12814351


    Sources:
    NCI

  • Ensembl: ENSG00000059804

    • Version: 101_38

    Alternate Names:
    SLC2A3 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • TdgClinicalTrial: P11169

    • Version: January-2014

    Alternate Names:
    SLC2A3 Gene Symbol

    Gene Info:
    Target Class Transporters
    Target Subclass TC:2.A.1.1.91

    Publications:

  • RussLampel: ENSG00000059804

    • Version: 26-July-2011

    Alternate Names:
    ENSG00000059804 Ensembl Gene Id
    SLC2A3 Display Id
    SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER, MEMBER 3 (GLUCOSE TRANSPORTER TYPE 3, BRAIN). [SOURCE:UNIPROT/SWISSPROT;ACC:P11169] Description

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • NCI: SLC2A3

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Phillips et al., 2005, Differential regulation of the GLUT1 and GLUT3 glucose transporters by growth factors and pro-inflammatory cytokines in equine articular chondrocytes., Vet. J.
    Augustin et al., 2003, Mitogenic and anti-apoptotic activity of insulin on bovine embryos produced in vitro., Reproduction

  • DTC: SLC2A3

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Park JB, 2001, Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells., J Nat Prod

  • Pharos: SLC2A3

    • Version: 01-February-2022

    Alternate Names:
    Solute carrier family 2, facilitated glucose transporter member 3 Gene Name
    P11169 UniProt ID

    Gene Info:

    Gene Categories:
    TRANSPORTER

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21